These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8551061)

  • 1. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Hardy RE
    Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
    Polívková J; Vosmiková K; Pospísil J; Poucková P
    Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
    Polívková J; Vosmiková K; Horák L
    Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid bound sialic acid in cancer patients.
    Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
    Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of serum activity of angiotensin-converting enzyme as a tumor marker.
    Varela AS; Bosco Lopez Saez JJ
    Oncology; 1993; 50(6):430-5. PubMed ID: 8233282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sialic acid and alkaline DNase in breast cancer.
    Raval GN; Parekh LJ; Patel MM; Patel PS; Rawal RM; Balar DB; Patel DD
    Int J Biol Markers; 1997; 12(2):61-7. PubMed ID: 9342634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of serum lipid-bound sialic acid in bladder tumours.
    Oztokatli A; Ozkardeş H; Ovül E; Erol D
    Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM; Schwartz MK
    Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
    Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
    Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy.
    O'Kennedy R; Berns G; Moran E; Smyth H; Carroll K; Thornes RD; O'Brien A; Fennelly J; Butler M
    Cancer Lett; 1991 Jun; 58(1-2):91-100. PubMed ID: 2049789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen and protein-bound sialic acid in the management of head and neck cancer.
    Bhatavdekar JM; Patel DD; Vora HH; Balar DB
    Int J Biol Markers; 1991; 6(4):237-40. PubMed ID: 1795131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
    Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
    Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid-bound sialic acid as a marker in breast cancer.
    Dnistrian AM; Schwartz MK; Katopodis N; Fracchia AA; Stock CC
    Cancer; 1982 Nov; 50(9):1815-9. PubMed ID: 7116306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.